# US 2015/0105459 A1 · Lichesterinic acid and the derivatives of same as pigmentation inhibitors

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0105459 A1
- Document ID: US20150105459A1
- Status: Published application
- Kind: A1
- Application number: 14/395,169
- Filed: 2013-04-18
- Published: 2015-04-16
- Earliest claimed: 2012-04-18
- Assignees: Centre National De La Recherche Scientique (Cnrs); Universite De Rennes 1; Centre Hospitalier Universitaire Pontchaillou
- Applicants: Centre National de la Recherche Scientique - CNRS; Universite de Rennes 1; Centre Hospitalier Universitaire Pontchaillou
- Inventors: Joel Boustie; Marie-Dominique Galibert-Anne; Francoise Lohezic-le Devehat; Marylene Chollet-Krugler; Sophie Tomasi; Nicolas Mouchet; Beatrice Legouin-Gardadennec
- Web page: https://patentgrep.com/patent/US20150105459A1

## CPC

- A61K 8/4973: {with oxygen as the only hetero atom}
- A61K 31/365: Lactones
- A61P 17/00: Drugs for dermatological disorders
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61Q 19/02: for chemically bleaching or whitening the skin
- C07D 307/68: Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

The invention relates to the cosmetic use of a compound chosen from the compounds of formula (A) and the salts of same as an agent for depigmenting the skin and/or keratinous appendages.

## Claims

### Claim 1

The cosmetic use of a compound chosen from the compounds of following formula (A) and salts thereof, in their dextrorotatory (+) form:
in which R4 represents a hydrogen atom, an n-butyl radical, an unsubstituted phenyl radical, an unsubstituted phenethyl radical or a COOR group, where R=Na, H, methyl or ethyl,
and R5 is chosen from a hydrogen atom, a linear or branched C1 to C13 alkyl radical, CH2CCH, Ph, PhCH2, PhCH2CH2, a (linear C3 to C12 alkyl)-CF3 radical, a linear C2 to C13 alkyl radical with an unsaturation, in the terminal or non-terminal position, and (CH2)13COR6 where R6=OCH3, OH or CH3,
and the compounds of formula (A) and salts thereof, in their levorotatory (−) form, in which R4 is as previously described and R5 is a linear or branched C1 to C5 alkyl radical,
as an agent for depigmenting the skin and/or the appendages.

### Claim 2

A compound chosen from the compounds of following formula (A) and salts thereof, in their dextrorotatory (+) form:
in which R4 represents a hydrogen atom, an n-butyl radical, an unsubstituted phenyl radical, an unsubstituted phenethyl radical or a COOR group, where R=Na, H, methyl or ethyl,
and R5 is chosen from a hydrogen atom, a linear or branched C1 to C13 alkyl radical, CH2CCH, Ph, PhCH2, PhCH2CH2, a (linear C3 to C12 alkyl)-CF3 radical, a linear C2 to C13 alkyl radical with an unsaturation, in the terminal or non-terminal position, and (CH2)13COR6 where R6=OCH3, OH or CH3,
and the compounds of formula (A) and salts thereof, in their levorotatory (−) form, in which R4 is as previously described and R5 is a linear or branched C1 to C5 alkyl radical,
for use in depigmenting the skin and/or the appendages.

### Claim 3 (depends on 1)

The cosmetic use of a compound as claimed in claim 1, characterized in that R5 is a linear or branched C1 to C13 alkyl radical chosen from the methyl, ethyl, isopropyl, n-propyl, n-butyl, i-butyl and t-butyl radicals, the —C5H11 radical, the —C9H19 radical and the —C13H27 radical.

### Claim 4 (depends on 1)

The cosmetic use of a compound as claimed in claim 1, characterized in that R5 is a C2 to C13 alkyl radical with a non-terminal cis-unsaturation, preferably the cis-C2H5CHCHC5H10— radical.

### Claim 5 (depends on 1)

The cosmetic use of a compound as claimed in claim 1, characterized in that the compound or salt thereof, in dextrorotatory form, is present in an amount of between 0.0001% and 10% by weight relative to the total weight of the composition.

### Claim 6 (depends on 1)

The cosmetic use of a compound as claimed in claim 1, characterized in that R4 is the COOH group, and R5 is a linear or branched C1 to C13 alkyl radical.

### Claim 7 (depends on 1)

The cosmetic use of a compound as claimed in claim 1, characterized in that the compound is chosen from (+)-lichesterinic acid, (+)-3-methyl-5-nonylparaconic acid and (+)-3-methyl-5-pentylparaconic acid.

### Claim 8

A compound chosen from the compounds of formula (A) and salts thereof, in their dextrorotatory (+) form:
in which R4 represents a hydrogen atom, an n-butyl radical, an unsubstituted phenyl radical, an unsubstituted phenethyl radical or a COOR group, where R=Na, H, methyl or ethyl,
and R5 is chosen from a (linear C3 to C12 alkyl)-CF3 radical and a linear C2 to C13 alkyl radical with an unsaturation, in the terminal or non-terminal position,
and the compounds of formula (A) and salts thereof, in their levorotatory (−) form, in which R4 is as previously described and R5 is a linear or branched C1 to C5 alkyl radical.

### Claim 9 (depends on 8)

The compound as claimed in claim 8, characterized in that R5 is the cis-C2H5CHCHC5H10— radical.

### Claim 10 (depends on 8)

The compound as claimed in claim 8, for use as a medicament.

### Claim 11 (depends on 2)

The cosmetic use of a compound as claimed in the compound for use as claimed in claim 2, characterized in that R5 is a linear or branched C1 to C13 alkyl radical chosen from the methyl, ethyl, isopropyl, n-propyl, n-butyl, i-butyl and t-butyl radicals, the —C5H11 radical, the —C9H19 radical and the —C13H27 radical.

### Claim 12 (depends on 2)

The cosmetic use of a compound as claimed in the compound for use as claimed in claim 2, characterized in that R5 is a C2 to C13 alkyl radical with a non-terminal cis-unsaturation, preferably the cis-C2H5CHCHC5H10— radical.

### Claim 13 (depends on 3)

The cosmetic use of a compound as claimed in claim 3, characterized in that the compound or salt thereof, in dextrorotatory form, is present in an amount of between 0.0001% and 10% by weight relative to the total weight of the composition.

### Claim 14 (depends on 4)

The cosmetic use of a compound as claimed in claim 4, characterized in that the compound or salt thereof, in dextrorotatory form, is present in an amount of between 0.0001% and 10% by weight relative to the total weight of the composition.

### Claim 15 (depends on 2)

The cosmetic use of the compound for use as claimed in claim 2, characterized in that the compound or salt thereof, in dextrorotatory form, is present in an amount of between 0.0001% and 10% by weight relative to the total weight of the composition.

### Claim 16 (depends on 3)

The cosmetic use of the compound for use as claimed in claim 3, characterized in that the compound or salt thereof, in dextrorotatory form, is present in an amount of between 0.0001% and 10% by weight relative to the total weight of the composition.

### Claim 17 (depends on 4)

The cosmetic use of the compound for use as claimed in claim 4, characterized in that the compound or salt thereof, in dextrorotatory form, is present in an amount of between 0.0001% and 10% by weight relative to the total weight of the composition.

### Claim 18 (depends on 3)

The cosmetic use of a compound as claimed in claim 3, characterized in that R4 is the COOH group, and R5 is a linear or branched C1 to C13 alkyl radical.

### Claim 19 (depends on 2)

The cosmetic use of the compound for use as claimed in claim 2, characterized in that R4 is the COOH group, and R5 is a linear or branched C1 to C13 alkyl radical.

### Claim 20 (depends on 1)

The cosmetic use of a compound as claimed in claim 1, characterized in that R4 is the COOH group, and R5 is a linear or branched C1 to C13 alkyl radical.

### Claim 21 (depends on 3)

The cosmetic use of a compound as claimed in claim 3, characterized in that the compound is chosen from (+)-lichesterinic acid, (+)-3-methyl-5-nonylparaconic acid and (+)-3-methyl-5-pentylparaconic acid.

### Claim 22 (depends on 2)

The cosmetic use of the compound for use as claimed in claim 2, characterized in that the compound is chosen from (+)-lichesterinic acid, (+)-3-methyl-5-nonylparaconic acid and (+)-3-methyl-5-pentylparaconic acid.

### Claim 23 (depends on 3)

The cosmetic use of the compound for use as claimed in claim 3, characterized in that the compound is chosen from (+)-lichesterinic acid, (+)-3-methyl-5-nonylparaconic acid and (+)-3-methyl-5-pentylparaconic acid.

### Claim 24 (depends on 9)

The compound as claimed in claim 9, for use as a medicament.
